How untreated sleep apnea can lead to serious health risks / FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. / FDA approves Zepbound for sleep apnea in obese adults / FDA approves first medication for obstructive sleep apnea, which also promotes weight loss / Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea / FDA approves weight loss drug Zepbound to treat obstructive sleep apnea / Weight loss drug gets US nod to treat sleep apnea; India launch likely next year / FDA approves weight loss drug Zepbound for sleep apnea / The FDA just approved Eli Lilly's Zepbound for sleep apnea -- and Medicare coverage could be next